MACOM (MTSI) Reports Earnings Tomorrow. What To Expect
Stock Story
Published Nov 08, 2023 02:01AM ET
Updated Nov 08, 2023 07:02AM ET
MACOM (MTSI) Reports Earnings Tomorrow. What To Expect
Network chips maker MACOM Technology Solutions (NASDAQ: MTSI) will be reporting results tomorrow before market hours. Here's what to expect.
Last quarter MACOM reported revenues of $148.5 million, down 13.8% year on year, in line with analyst expectations. It was a weaker quarter for the company, with a decline in its operating margin and an increase in its inventory levels.
Is MACOM buy or sell heading into the earnings? Find out by reading the original article on StockStory.
This quarter analysts are expecting MACOM's revenue to decline 15.6% year on year to $150.3 million, a deceleration on the 14.8% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.55 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company has a history of exceeding Wall St's expectations, beating revenue estimates every single time over the past two years on average by 0.7%.
Looking at MACOM's peers in the analog semiconductors segment, some of them have already reported Q4 earnings results, giving us a hint what we can expect. Skyworks Solutions (NASDAQ:SWKS)'s revenues decreased 13.4% year on year, beating analyst estimates by 0.3% and Magnachip reported revenue decline of 14% year on year, missing analyst estimates by 1%. Skyworks Solutions traded down 7% on the results, Magnachip traded flat after the results.
Read the full analysis of Skyworks Solutions's and Magnachip's results on StockStory.
The fears around raising interest rates have been putting pressure on tech stocks and while some of the analog semiconductors stocks have fared somewhat better, they have not been spared, with share price declining 6% over the last month. MACOM is down 10.6% during the same time, and is heading into the earnings with analyst price target of $86.1, compared to share price of $73.9.
The author has no position in any of the stocks mentioned.
Get The News You Want
Written By: Stock Story
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.